Health & Fitness
Health and Fitness
Health and Fitness 
Wed, March 9, 2011
Tue, March 8, 2011
Law Office of Brodsky & Smith, LLC Announces Investigation of TomoTherapy Incorporated
BALA CYNWYD, Pa.--([ BUSINESS WIRE ])--Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of TomoTherapy Incorporated (aTomoTherapya or the aCompanya) (Nasdaq: TOMO) relating to the proposed acquisition by Accuray Incorporated (aAccuraya).
Under the terms of the transaction, TomoTherapy shareholders would receive $3.15 in cash and 0.1648 shares of Accuray stock for each share of TomoTherapy common stock they own. The transaction values TomoTherapy stock at approximately $4.80 per share. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of TomoTherapy by not acting in TomoTherapy shareholders' best interests in connection with the sale process to Accuray. The transaction may undervalue TomoTherapy as after the transaction was announced shares of Accuray fell approximately 10% and an analyst has set a $5.00 price target on shares of TomoTherapy stock.
If you own shares of TomoTherapy stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at [ investorrelations@brodsky-smith.com ], visiting [ http://brodsky-smith.com/269-tomo-tomotherapy-incorporated.html ], or by calling toll free 877-LEGAL-90.